An extensive description of the methods for diagnosing CPTII deficiency (i.e., clinical presentation, pathobiochemical characteristics, molecular genetic aspects, detectable biomarkers and genotype-phenotype analysis) has been recently published by Joshi and Zierz (2020). This evidence concerns the gene CPT2 and hyperinsulinemic hypoglycemia, familial, 4.